Apotex' Antitrust Claims In Patent Case Approved
A federal judge overseeing the patent battle over the market for the blockbuster drug Plavix has allowed Apotex Inc. to assert antitrust counterclaims against the plaintiffs, but ruled those issues will...To view the full article, register now.
Already a subscriber? Click here to view full article